Start - up Erasca has launched with $ 42 million of series A funding . The San Diego - based pharmaceutical company says it aims to concentrate initially on small - molecule drugs for the treatment of solid tumors . It describes its goal as not just treating cancer , but treating residual disease , using numerous therapeutic modalities , including alternative therapies .
Start-up Erasca has launched with $42m of series A funding. The San Diego-based pharmaceutical company said it aims to concentrate initially on small-molecule drugs for the treatment of solid tumours. It describes its goal as not just treating cancer, but eradicating residual disease, using numerous therapeutic modalities, including combination therapies.